高级检索
当前位置: 首页 > 详情页

IS TRADITIONAL CHINESE MEDICINE A GOOD OPTION IN METHOTREXATE-BASED COMBINATION THERAPIES IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP)

机构: [1]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China [2]Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands [3]Guangzhou Univ Chinese Med, Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Peoples R China [4]Guangzhou Univ Chinese Med, Guangdong Hong Kong Macau Joint Lab Chinese Med &, Guangzhou, Peoples R China [5]Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China
出处:
ISSN:

关键词: Clinical Trials Randomized control trial Rheumatoid arthritis

摘要:
Background: Former findings suggested that MTX-based combination therapies show improved efficacy and safety compared to monotherapy [1]. Several studies [2] have been conducted analysis on MTX-based combination therapies, but there is a lack of systematic analysis involving MTX+TCM (Traditional Chinese medicine) therapies. Objectives: To assess the effectiveness and adverse events of Methotrexate-based (MTX-based) combination therapies(especially MTX + TCM therapies) in rheumatoid arthritis (RA) treatment. Methods: A comprehensive search of PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure (CNKI), the Database for Chinese Technical Periodicals and Wanfang data was done without language restriction. A systematic review and network meta-analysis included randomized controlled trials of MTX-based combination therapies and methotrexate monotherapy. The ability of different regimens to reduce rheumatoid factors and inflammatory indicators and the probability of adverse reactions were compared. This study has been registered with PROSPERO under the number CRD42022265799. Results: A total of 37 studies, including 3119 patients, were eligible for inclusion. Meta-analysis results showed that methotrexate combined with other DMARDs or Traditional Chinese Medicine (TCM) could reduce serum Rheumatoid Factor (RF) and C-reactive protein (CRP) levels to some extent, but the therapies combined with TCM were more effective and had a lower rate of adverse effects. The results of RF reducing ability were ranked in ascending order: MTX- +LEF+TCM > MTX+SSZ+HCQ > MTX+LEF >MTX+TCM >MTX+HCQ >MTX. While the results of CRP reducing ability were ranked in ascending order: MTX+LEF+TCM>MTX+SSZ+HCQ>MTX+LEF>MTX+TCM>MTX+HCQ. Conclusion: Overall, MTX-based combination therapies are an effective treatment, and the combination of TCM and MTX-based combination therapies is more effective and safer. For treating rheumatoid arthritis or patients with an inadequate response to MTX, MTX-based combination therapies remain an alternative, cost-effective option. To support and validate the potential of TCM and MTX-based combination therapies in treating RA, large-scale, high-quality RCTs should be conducted in the future to provide more accurate and complete data.

语种:
WOS:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 医学
小类 | 1 区 风湿病学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 风湿病学
JCR分区:
出版当年[2021]版:
Q1 RHEUMATOLOGY
最新[2023]版:
Q1 RHEUMATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号